Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Taki Chemical Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Taki Chemical has a total shareholder equity of ¥37.0B and total debt of ¥690.0M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are ¥55.8B and ¥18.8B respectively. Taki Chemical's EBIT is ¥1.6B making its interest coverage ratio -4.1. It has cash and short-term investments of ¥3.8B.
Anahtar bilgiler
1.9%
Borç/özkaynak oranı
JP¥690.00m
Borç
| Faiz karşılama oranı | -4.1x |
| Nakit | JP¥3.83b |
| Eşitlik | JP¥37.01b |
| Toplam yükümlülükler | JP¥18.80b |
| Toplam varlıklar | JP¥55.81b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 4025's short term assets (¥24.2B) exceed its short term liabilities (¥8.9B).
Uzun Vadeli Yükümlülükler: 4025's short term assets (¥24.2B) exceed its long term liabilities (¥9.9B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 4025 has more cash than its total debt.
Borcun Azaltılması: 4025's debt to equity ratio has reduced from 4.6% to 1.9% over the past 5 years.
Borç Kapsamı: 4025's debt is well covered by operating cash flow (432.2%).
Faiz Kapsamı: 4025 earns more interest than it pays, so coverage of interest payments is not a concern.